288 results on '"Spuler S"'
Search Results
52. Calibrating airborne measurements of airspeed, pressure and temperature using a Doppler laser air-motion sensor
53. P.41 - High fat infiltration and increased muscle T2 measured by 1H-NMR in a new dysferlinopathy murine model
54. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice
55. P5.60 Does vitamin D deficiency support myalgia?
56. P2.55 Mstn/Dysf double knockout mice gain muscle mass but no strength
57. P5.67 Electrical muscle stimulation in early severe critical illness prevents type 2 fiber atrophy
58. 248 A GENETIC VARIANT WITHIN CAVEOLIN-3 PROTECTS AGAINST STATIN-INDUCED MYOPATHY
59. Clinical features of facioscapulohumeral muscular dystrophy 2
60. P3.27 The amazing regenerative potency of human satellite cells - analysis in single fibers
61. P3.16 Myostatin inhibits differentiation of normal and dysferlin-deficient human skeletal myoblasts – similarities and differences
62. P1.18 Dysferlin peptides elicit functional recovery in dysferlin deficient muscular dystrophy
63. P1.53 GLUT4 expression in early critical illness myopathy
64. P1.32 A genetic variant within caveolin-3 protects against statin-induced myopathy
65. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance
66. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge
67. MS552 UNMASKING CHRONIC MUSCLE DISEASE IN 3 PATIENTS WITH STATIN INDUCED MYOPATHY
68. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy
69. G.P.10.04 Is complement inhibition a potential therapy in dysferlin-deficient muscular dystrophy?
70. Caveolinopathien – Wegbereiter für Insulinresistenz?
71. Muscle and nerve pathology in Dunnigan familial partial lipodystrophy
72. Progressive muscle atrophy with hypokalaemic periodic paralysis and calcium channel mutation
73. Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen
74. G.P.284: Dysferlinopathy caused by protein misfolding: The novel murine animal model Dysf-MMex38
75. G.P.63: Identification of widespread alterations of RNA metabolism in sporadic inclusion-body myositis using SILAC-based quantitative proteomics
76. Differenzialdiagnostik eines kongenitalen myasthenen Syndroms
77. Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.
78. Quantitative assessment of MRI lesion load in multiple sclerosis: A comparison of conventional spin-echo with fast fluidattenuated inversion recovery
79. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS
80. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis
81. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane.
82. Towards Developing a Micropulse Differential Absorption Lidar to Measure Atmospheric Temperature
83. A Micro-Pulse Differential Absorption Lidar Test Network
84. Poisson Total Variation Denoising for Micropulse Water Vapor DIAL
85. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
86. Cardiac involvement in sporadic inclusion-body myositis.
87. Highly purified oligo-His tagged human recombinant a~1-AChR is immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis
88. Multiple sclerosis: prospective analysis of TNF-a and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity
89. Micro-pulse, differential absorption lidar (dial) network for measuring the spatial and temporal distribution of water vapor in the lower atmosphere
90. The role of autoimmune t lymphocytes in the pathogenesis of multiple sclerosis
91. Advances in eye-safe atmospheric volume imaging lidar
92. FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy
93. CAMS — Compact atmospheric multi-species spectrometer.
94. P.389 - Development of primary human satellite cells into an advanced therapeutic medicinal product (ATMP).
95. Clinical Outcome Study in Dysferlinopathy: Medical comorbidities and polytherapy in a large population of dysferlinopathy patients
96. Clinical Outcome Study for Dysferlinopathy: Three years of natural history data for clinical trial readiness
97. Design Of A Low Cost Diode-Laser-Based High Spectral Resolution Lidar (HSRL)
98. Advances in Diode-Laser-Based Water Vapor Differential Absorption Lidar
99. Backscatter Matrix Observations by The GV-HSRL
100. A Micropulse eye-safe all-fiber molecular backscatter coherent temperature lidar
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.